Luke Evnin, Director at Werewolf Therapeutics, Inc. (HOWL), sold 71,054 shares at $0.64 ($46K) on 2026-01-05, disclosed to the SEC on 2026-01-07.
Open-market sale of $46k HOWL by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $0.64 | 18,378 | $12K | 25.6% |
| 2 | $0.65 | 40,761 | $26K | 57.7% |
| 3 | $0.64 | 11,915 | $8K | 16.6% |
| Total | $0.65 avg | 71,054 | $46K | 100% |
| Filing → |
| HOWL | SELL | 2026-06-10 | $28K | — | Filing → |
| HOWL | SELL | 2026-06-08 | $43K | — | Filing → |
| HOWL | SELL | 2026-06-03 | $64K | — | Filing → |